{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"22.05","upperLimit":"33.8","value":"27.43"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"75"}],"units":"Participants"}],"description":"Median time to death in months will be reported","dispersionType":"95% Confidence Interval","groups":[{"description":"20 mg/m2 day 1 of first cycle then escalated to 70 mg/m2 for all subsequent doses) given on days 1, 8, and 15 of a 28 day cycle plus weekly oral dexamethasone (\\< 70 years, 40 mg; ≥ 70 years 20mg) and cyclophosphamide 300 mg/m2 capped at 500 mg\n\nCarfilzomib\n\nCyclophosphamide\n\nDexamethasone","id":"OG000","title":"Carfilzomib Plus Cyclophosphamide Plus Dexamethasone"}],"paramType":"MEDIAN","populationDescription":"All treated patients","reportingStatus":"POSTED","timeFrame":"3 years","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"months"}